Dr. Douglas W. Morrell Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 606 E 11th St, Rushville, IN 46173 Phone: 765-932-2965 Fax: 765-932-4859 |
Rush County Health Department Clinic/Center - Public Health, State or Local Medicare: Not Enrolled in Medicare Practice Location: 101 E 2nd St Rm 105, Rushville, IN 46173 Phone: 765-932-3103 |
Meridian Health Services Corp-rushville Clinic/Center - Community Health Medicare: Not Enrolled in Medicare Practice Location: 509 Harcourt Way, Rushville, IN 46173 Phone: 765-932-3699 Fax: 765-932-4164 |
Rmh Healthcare Associates Rural Health Clinic Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 201 Conrad Harcourt Way Ste A, Rushville, IN 46173 Phone: 765-932-7591 Fax: 765-932-7576 |
News Archive
Scientists and educators alike have long known that cramming is not an effective way to remember things. With their latest findings, researchers at the RIKEN Brain Science Institute in Japan, studying eye movement response in trained mice, have elucidated the neurological mechanism explaining why this is so.
According to a new Nanos Research poll, Canadians rate physicians and pharmacists highest among 18 professions, when it comes to honesty and ethics. Seventy-seven per cent of respondents call medical doctors' standards of honesty and ethics "high" or "very high", while the figure was 73 per cent for community pharmacists.
Among patients undergoing incisional hernia repair, the use of mesh to reinforce the repair was associated with a lower risk of hernia recurrence over 5 years compared with when mesh was not used, although with long-term follow-up, the benefits attributable to mesh were offset in part by mesh-related complications, according to a study published online by JAMA.
Life Spine announced today that the U.S. Food and Drug Administration (FDA) has given 510(k) marketing clearance to both the DYNA-LINK Spinal System and the PRESIDIO Spinal Plating System.
KYTHERA Biopharmaceuticals, Inc., a privately-held biotechnology company focused on the development and commercialization of prescription products in aesthetic medicine, today announced the initiation of two pivotal U.S. Phase III trials of ATX-101, a first-in-class injectable drug under clinical investigation for the reduction of submental (under the chin) fat.
› Verified 5 days ago